718 related articles for article (PubMed ID: 34072869)
1. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
[TBL] [Abstract][Full Text] [Related]
2. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
[TBL] [Abstract][Full Text] [Related]
3. Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC.
Sano K; Atarashi R; Satoh K; Ishibashi D; Nakagaki T; Iwasaki Y; Yoshida M; Murayama S; Mishima K; Nishida N
Mol Neurobiol; 2018 May; 55(5):3916-3930. PubMed ID: 28550528
[TBL] [Abstract][Full Text] [Related]
4. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Method for the Determination of Aggregated α-Synuclein in DLB Patient Using RT-QuIC Assay.
Park SJ; Lee YJ; Park JH; Jin HT; Choi MJ; Jung CG; Akatsu H; Choi EK; Kim YS
Protein Pept Lett; 2021; 28(1):115-120. PubMed ID: 32310037
[TBL] [Abstract][Full Text] [Related]
6. Seeding variability of different alpha synuclein strains in synucleinopathies.
Candelise N; Schmitz M; Llorens F; Villar-Piqué A; Cramm M; Thom T; da Silva Correia SM; da Cunha JEG; Möbius W; Outeiro TF; Álvarez VG; Banchelli M; D'Andrea C; de Angelis M; Zafar S; Rabano A; Matteini P; Zerr I
Ann Neurol; 2019 May; 85(5):691-703. PubMed ID: 30805957
[TBL] [Abstract][Full Text] [Related]
7. RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein.
Srivastava A; Alam P; Caughey B
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454165
[TBL] [Abstract][Full Text] [Related]
8. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.
Hall S; Orrù CD; Serrano GE; Galasko D; Hughson AG; Groveman BR; Adler CH; Beach TG; Caughey B; Hansson O
Acta Neuropathol Commun; 2022 Jun; 10(1):90. PubMed ID: 35733234
[TBL] [Abstract][Full Text] [Related]
9. α-Synuclein Seeding Assay Using RT-QuIC.
Okuzumi A; Hatano T; Fukuhara T; Ueno S; Nukina N; Imai Y; Hattori N
Methods Mol Biol; 2021; 2322():3-16. PubMed ID: 34043187
[TBL] [Abstract][Full Text] [Related]
10. [Real-time Quaking-induced Conversion Analysis of Prion-like Seeding Activity of Pathological α-Synuclein].
Sano K
Yakugaku Zasshi; 2019; 139(7):999-1005. PubMed ID: 31257259
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
[TBL] [Abstract][Full Text] [Related]
12. Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC.
Groveman BR; Orrù CD; Hughson AG; Raymond LD; Zanusso G; Ghetti B; Campbell KJ; Safar J; Galasko D; Caughey B
Acta Neuropathol Commun; 2018 Feb; 6(1):7. PubMed ID: 29422107
[TBL] [Abstract][Full Text] [Related]
13. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
[TBL] [Abstract][Full Text] [Related]
14. The Alpha-Synuclein RT-QuIC Products Generated by the Olfactory Mucosa of Patients with Parkinson's Disease and Multiple System Atrophy Induce Inflammatory Responses in SH-SY5Y Cells.
De Luca CMG; Consonni A; Cazzaniga FA; Bistaffa E; Bufano G; Quitarrini G; Celauro L; Legname G; Eleopra R; Baggi F; Giaccone G; Moda F
Cells; 2021 Dec; 11(1):. PubMed ID: 35011649
[TBL] [Abstract][Full Text] [Related]
15. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.
Graves NJ; Gambin Y; Sierecki E
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569510
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
Bargar C; De Luca CMG; Devigili G; Elia AE; Cilia R; Portaleone SM; Wang W; Tramacere I; Bistaffa E; Cazzaniga FA; Felisati G; Legname G; Di Fonzo A; Xu R; Gunzler SA; Giaccone G; Eleopra R; Chen SG; Moda F
Mol Neurodegener; 2021 Dec; 16(1):82. PubMed ID: 34895275
[TBL] [Abstract][Full Text] [Related]
18. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
[TBL] [Abstract][Full Text] [Related]
19. Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.
Brockmann K; Quadalti C; Lerche S; Rossi M; Wurster I; Baiardi S; Roeben B; Mammana A; Zimmermann M; Hauser AK; Deuschle C; Schulte C; Waniek K; Lachmann I; Sjödin S; Brinkmalm A; Blennow K; Zetterberg H; Gasser T; Parchi P
Acta Neuropathol Commun; 2021 Oct; 9(1):175. PubMed ID: 34717775
[TBL] [Abstract][Full Text] [Related]
20. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
